Dave Bauer has a multidisciplinary scientific background, including undergraduate degrees in biology and physics, along with a PhD in biophysics. He has years of experience in both real-time PCR and digital PCR, including working on analytical method development for cell therapeutics, supporting and training customers as a field applications specialist, and roles focused on digital PCR products and applications. Dave is drawn to digital PCR technology for its unique analytical capabilities, which bring benefits to many areas of biological research.

Christina Engel holds a Master of Science in Molecular Biomedicine from Heinrich-Heine-University in Düsseldorf Germany, where she focused on oncology and breast cancer research. Christina joined QIAGEN in 2023, and has since been responsible for product portfolios in qPCR, dPCR microbial assays and dPCR gene expression assays.

Michael Menear holds a BSc in Forensic Science and Analysis from Atlantic Technological University and an MRes in Forensic Science from King’s College London. He is currently pursuing a PhD in Forensic Genetics at King’s College London with a focus on DNA extraction and forensic analysis.